M&A - COOPER COMPANIES, INC.

Form Type: 10-Q

Filing Date: 2025-03-07

Corporate Action: Acquisition

Type: Update

Accession Number: 000071140425000015

Filing Summary: For the quarterly period ended January 31, 2025, The Cooper Companies, Inc. reports a net income of $104.3 million, reflecting an increase from $81.2 million in the prior year. Net sales for the quarter were $964.7 million, up from $931.6 million, demonstrating a robust demand for the company’s products. The cost of sales totaled $304.5 million, resulting in a gross profit of $660.2 million. Notably, the selling, general and administrative expenses increased slightly to $387.9 million compared to $380.9 million in the same period last year. The company reports several acquisitions, notably CooperSurgical's acquisition of obp Surgical on August 1, 2024, for $100 million, and a fertility company for $33.5 million in June 2024. An important acquisition involved assets from Cook Medical, completed on November 1, 2023, costing $300 million with installments due in the following years. The balance sheet reflects total assets of $12.22 billion and total liabilities of $4.09 billion, demonstrating a solid financial position. Comprehensive income for the quarter was $35.6 million, with specific attention to elements affecting earnings such as foreign currency adjustments and cash flow hedges. The document also highlights ongoing initiatives regarding the company’s accounting policies and notable operating segments within the business, including Coopervision and Coopersurgical. The company remains compliant with regulatory filing requirements, affirming its operational stability and growth amidst industry challenges.

Document Link: View Document